Carla Bauer

Director - Oncology Search & Evaluation, Business Development & Licensing Merck & Co

Seminars

Wednesday 18th February 2026
Pharma Perspectives Panel Discussion: Successfully Engaging with Large Pharma Companies to Secure Future Partnerships for GBM Therapeutic Development
3:30 pm
  • Identifying specific data packages, preclinical models and clinical milestones that will make a GBM asset attractive for a partnership, beyond scientific novelty
  • Strategies for pitching, due diligence considerations and building collaborative relationships to effectively engage with big pharma business development teams to secure a deal
  • Insights into creative deal terms, IP considerations and defining clear roles and responsibilities to ensure both partners are aligned on the path to clinical and commercial success
Carla bauer, speaking at 7th Glioblastoma Drug Development Summit